| Dr Gregory P Moore Ii, MD | |
|
7101 Jahnke Rd, Suite 280, Richmond, VA 23225-4017 | |
| (804) 272-5508 | |
| (804) 323-7564 |
| Full Name | Dr Gregory P Moore Ii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 7101 Jahnke Rd, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881672699 | NPI | - | NPPES |
| 006215572 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 0101050166 (Virginia) | Primary |
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 0101050166 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cjw Medical Center | Richmond, VA | Hospital |
| Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Richmond Specialty Care Llc | 8022440056 | 260 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Entity Name | James River Ob Gyn, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952358152 PECOS PAC ID: 8628064599 Enrollment ID: O20040424000239 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Entity Name | Mary Washington Healthcare Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295999852 PECOS PAC ID: 2769546530 Enrollment ID: O20090123000298 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Entity Name | Elite Womens Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073872156 PECOS PAC ID: 2769648682 Enrollment ID: O20120723000102 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory P Moore Ii, MD 301 Virginia St, Unit 1101, Richmond, VA 23219-4145 Ph: (804) 389-5000 | Dr Gregory P Moore Ii, MD 7101 Jahnke Rd, Suite 280, Richmond, VA 23225-4017 Ph: (804) 272-5508 |
News Archive
The European Perinatal Health Report released by the Euro-Peristat project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland.
The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin-and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases.
› Verified 6 days ago
James T Christmas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7601 Forest Ave, Suite 336, Richmond, VA 23229 Phone: 804-289-4972 Fax: 804-289-4674 | |
Katherine M Czyszczon, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 401 N 11th St, Richmond, VA 23219 Phone: 804-828-4409 Fax: 804-828-6084 | |
Stewart James Wetchler, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall Street, Richmond, VA 23298 Phone: 757-220-1246 Fax: 757-220-0835 | |
Dr. Jay E. Allard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1300 E Marshall St, Richmond, VA 23298 Phone: 804-828-9080 Fax: 804-828-3891 | |
Dr. Ponjola Coney, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Ob/gyn, Richmond, VA 23298 Phone: 804-828-4409 Fax: 804-828-6084 | |
Kimberly Rhea Earhart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7601 Forest Ave Ste 100, Richmond, VA 23229 Phone: 804-282-9479 | |
Robert E Petres, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8950 Fax: 804-560-7343 |